PlainRecalls
ModerateClass IITerminated

FDA Food recall · Reported November 20, 2013

Cellulase & Protease: APEX 10-639 A DIGESEB DIGESEB PLUS DIGESEB SUPER EB 10-14171 EB 10-16192 EB 12-11331 EB 12-9205 EB 14-14201 EB 15-13662 EB 18-13081 EB 7-12831 EB 7-12901 EB 7-14211 EB 8-15731 EL 5-7212 ENZIGEST N FIZYME # 1209 N GLOBAL 8-658 HERB 10-6973 HFI 4-7601 HFN 7-7113 META 10-185 NB 6-7812 NF 525 NHK 14-9451 NPC 7007 NPC 8008 NUTRO 8-7961 OHS - 9804 PROTHERA 18-9724 PROTHERA 19-9723 PROTHERA 8-12182 SD 7-581 SEB GLUTEN RELIEF SEB GLUTEN RELIEF

Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.

Recall #
F-0135-2014
Affected scope
13,685 kg
Initiated
October 3, 2013
Verify with FDA Food →
View my saved recalls

Specialty Enzymes & Biotechnologies recalled Cellulase & Protease: APEX 10-639 A DIGESEB DIGESEB PLUS DIGESEB SUPER EB 10-14171… - a moderate-severity action.

Cellulase & Protease: APEX 10-639 A DIGESEB DIGESEB PLUS DIGESEB SUPER EB 10-14171… was recalled by Specialty Enzymes & Biotechnologies in November 20, 2013. Reason: Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may c…. Check the official notice for the remedy. Verify recall #F-0135-2014 with the FDA Food before acting.

The recall

Specialty Enzymes & Biotechnologies issued this moderate-severity FDA Food recall-Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may c….

Moderate
severity level
Class II
classification
November 20, 2013
reported

Sourced from official FDA Food enforcement records. Verify recall #F-0135-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Food action (record #F-0135-2014) was formally reported on November 20, 2013, with the manufacturer initiating the action on October 3, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. Specialty Enzymes & Biotechnologies is listed as the recalling firm, operating out of Chino, CA. Federal records list the affected scope as 13,685 kg.

The documented reason for this recall is: Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol. Distribution data in the federal record shows the product reached: Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 2 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Food recalls over time

Where this recall sits in its category - 25,126 food recalls on record

-1,00001,0002,0003,000 20052008201120142017202020232026 481
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

13,685 kg

Related Recalls

6

2 from same agency

Product description

Cellulase & Protease: APEX 10-639 A DIGESEB DIGESEB PLUS DIGESEB SUPER EB 10-14171 EB 10-16192 EB 12-11331 EB 12-9205 EB 14-14201 EB 15-13662 EB 18-13081 EB 7-12831 EB 7-12901 EB 7-14211 EB 8-15731 EL 5-7212 ENZIGEST N FIZYME # 1209 N GLOBAL 8-658 HERB 10-6973 HFI 4-7601 HFN 7-7113 META 10-185 NB 6-7812 NF 525 NHK 14-9451 NPC 7007 NPC 8008 NUTRO 8-7961 OHS - 9804 PROTHERA 18-9724 PROTHERA 19-9723 PROTHERA 8-12182 SD 7-581 SEB GLUTEN RELIEF SEB GLUTEN RELIEF HNS UT 11-216 N VEGPANZYME 1213 VEGPANZYME 1X VEGPANZYME PLUS VT 11-693

Reason for recall

Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.

Recall Profile

Structured summary of the FDA Food recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number F-0135-2014
Date reported November 20, 2013
Date initiated October 3, 2013
Recalling firm Specialty Enzymes & Biotechnologies
Firm location Chino, CA
Affected scope 13,685 kg
Distribution Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy

Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (F-0135-2014) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Food before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Cellulase & Protease: APEX 10-639 A DIGESEB DIGESEB PLUS DIGESEB SUPER EB 10-14171 EB 10-16192 EB 12-11331 EB 12-9205 EB 14-14201 EB 15-13662 EB 18-13081 EB 7-12831 EB 7-12901 EB 7-14211 EB 8-15731 EL 5-7212 ENZIGEST N FIZYME # 1209 N GLOBAL 8-658 HERB 10-6973 HFI 4-7601 HFN 7-7113 META 10-185 NB 6-7812 NF 525 NHK 14-9451 NPC 7007 NPC 8008 NUTRO 8-7961 OHS - 9804 PROTHERA 18-9724 PROTHERA 19-9723 PROTHERA 8-12182 SD 7-581 SEB GLUTEN RELIEF SEB GLUTEN RELIEF HNS UT 11-216 N VEGPANZYME 1213 VEGPANZYME 1X VEGPANZYME PLUS VT 11-693. Recalled by Specialty Enzymes & Biotechnologies. Units affected: 13,685 kg.
Why was this product recalled?
Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.
Which agency issued this recall?
This recall was issued by the FDA Food on November 20, 2013. Severity: Moderate. Recall number: F-0135-2014.
Where was the recalled product distributed?
Distribution: Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy.
How do I check if my product is affected by a recall?
Check the product description and recall number (F-0135-2014) against your product. Visit the official FDA Food website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
What are the health risks of consuming a recalled food product?
Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Conair Recalls Over One Million Cuisinart Grill Brushes Due… →

Browse all Food recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported November 20, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.